Motivation: Indoles have been shown to play a significant role in cardiometabolic disorders.
INTRODUCTION
The gut microbiome communicates with its human host through a range of signalling metabolites that bind human targets and impact their signalling pathways, thus modulating human health (Nicholson, Holmes et al. 2005 , Holmes, Kinross et al. 2012 , Chilloux, Neves et al. 2016 . Among these metabolites, indoles -heterocyclic compounds produced upon bacterial degradation of tryptophan or plant metabolism -appear to be particularly relevant for human health. In the last three decades, metabonomic studies have consistently identified indole-containing molecules in human biofluids (Bales, Higham et al. 1984 , Danaceau, Anderson et al. 2003 , Duranton, Cohen et al. 2012 , Bouatra, Aziat et al. 2013 .
Indoles have been linked to deleterious phenotypes both in vitro and in vivo. For instance, in endothelial cells, 3-indoxylsulphate induced oxidative stress by modifying the balance between pro-and anti-oxidant mechanisms, stimulating the release of endothelial microparticles and diminishing endothelial-healing ability (Faure, Dou et al. 2006) . 3-Indoxylsulphate also aggravates cardiac fibrosis and cardiomyocyte hypertrophy (Yisireyili, Shimizu et al. 2013) . In clinical studies, levels of 3-indoxylsulphate seem to be a powerful predictor of overall and cardiovascular mortality (Barreto, Barreto et al. 2009 ). Another indole, indole-3-propionate, is involved in inflammatory mechanisms and in the maintenance of intestinal barrier integrity (Venkatesh, Mukherjee et al. 2014) . The production of indoles depends on gut bacterial action, and therefore is affected by microbiome interventions such as the use of antibiotics (Sun, Schnackenberg et al. 2013) or functional foods (Yang and Tarng 2018) . A number of bacterial species involved in different indole synthesis pathways have been described in the literature. Tryptophan can be directly converted to indole by tryptophanase, a bacterial lyase present in Bacteroides thetaiotaomicron, Proteus vulgaris and Escherichia coli (Jean and DeMoss 1968, Wesoly and Weiler 2012) ; indole is further conjugated in the liver to form 3-indoxylsulphate. Alternatively, tryptophan can be deaminated by Clostridium spp. and Lactobacillus spp., producing indole-3-pyruvate, indole-3-lactate, indole-3-acetate and 3-methylindole (Mohammed, Onodera et al. 2003 , Attwood, Li et al. 2006 , Whitehead, Price et al. 2008 , Wikoff, Anfora et al. 2009 , Wesoly and Weiler 2012 , Russell, Duncan et al. 2013 . Studies performed in gnotobiotic mice demonstrated that the production of another indolic compound, indole-3-propionate, was completely dependent on colonisation by Clostridium sporogenes (Wikoff, Anfora et al. 2009 ).
While a number of studies have evaluated the contribution of individual species to the formation of specific indoles, there is a need for a systematic approach to investigate indole synthesis in the context of the gut microbiota ecosystem. In this study, we have developed a computational workflow to predict the contribution of the gut microbiota to the production of disease-related metabolites, here exemplified for indoles. In particular, we used the Kyoto Encyclopaedia of Genes and Genomes (KEGG) (Kanehisa and Goto 2000) , a popular reference database comprising biological pathways and cellular processes, as a starting point to identify the metabolic reactions relevant for the production of indoles and the bacterial species involved in these reactions. We then used a BLASTP-based strategy (Altschul, Gish et al. 1990 ) to predict novel key gut microbial players involved in this metabolic network, offering new insights into the prokaryotic metabolism of tryptophan.
MATERIALS AND METHODS

Indole metabolic network
The MetaboSignal R/Bioconductor package (v.3.8) was used to build a KEGG-based tryptophan metabolic network (Rodriguez-Martinez, Ayala et al. 2017) . This network has a bipartite structure, where nodes represent two different biological entities: metabolites and reactions. A reaction-to-metabolite distance matrix was generated to identify reactions directly connected to indole-containing compounds. The tryptophan network was then filtered to include only reactions involved in indole production from tryptophan. The reactions from the indole synthesis network were linked to their corresponding organism-specific genes using a two-step procedure: 1) from reaction to KEGG ortholog (KO); 2) from KO to organism-specific genes. The indole synthesis network was further filtered, by excluding reactions which are not undertaken by human or prokaryotic organisms. Three reactions ("rn:R00681", "rn:R01971", "rn:R01973") were included in the network despite not being linked to a KO, because there is evidence that these reactions can occur in some bacterial species (Jean and DeMoss 1968 , Hornemann, Hurley et al. 1971 , Speedie, Hornemann et al. 1975 , Roberts and Rosenfeld 1977 , Takai, Ushiro et al. 1977 , Du, Alkhalaf et al. 2015 .
This network was visualized and customized in Cytoscape (v.3.4) (Shannon, Markiel et al. 2003) .
Gut microbial species
A dataset of gut microbial organisms was created by merging the list of gastrointestinal isolates reported at the Human Microbiome Project (HMP) Catalog (Turnbaugh, Ley et al. 2007 ) with additional species identified in cultivation studies (Rajilic-Stojanovic and de Vos 2014, Browne, Forster et al. 2016 , Lagier, Khelaifia et al. 2016 . Data from HMP were downloaded on 12 November 2018; and only isolates with complete sequences and annotation were included. The taxize R/CRAN package (v.0.9.6) (Chamberlain, Szoecs et al. 2018 ) was used to retrieve the taxon identifier (ID) as well as the phylum of each organism.
BLAST analysis
For each KO involved in indole metabolism, a FASTA file of concatenated prokaryotic protein sequences was generated. These FASTA files were used to run BLASTP searches against the non-redundant (rn) protein sequence database on 30 November 2018. BLASTP results were filtered using an E value cut-off of 1x10 -3 and 90 % sequence coverage; only hits with ≥ 95 % identity were retained.
Visualization of results
The results of the analysis were visualized using different approaches. For 3-indoxylsulphate, relevant bacterial species were grouped by phylum and visualized as a network in Cytoscape. For indole-3-acetate, a reaction-species heatmap color-coded according to the ability of a given bacterium to perform each reaction was generated. In order to highlight the most relevant species, the reaction-species matrix was filtered as follows: 1) three different paths leading to the production of indole-3-acetate from tryptophan were identified; 2) each reaction was assigned a value (reaction-value) reflecting its contribution to the corresponding path (i.e. 1/total number of reactions in the path); 3) each species was given a score (Species Contributor Score, SCS), calculated as the sum of the individual reaction-values.
RESULTS
Contribution of human and prokaryotic metabolic reactions to the production of indolic compounds
We generated a KEGG-based network illustrating the metabolic reactions involved in the production of indoles from tryptophan. The network was filtered to include only those metabolic reactions that can be performed by human or prokaryotic organisms. Based on this, 16 metabolites and 19 metabolic reactions (8 prokaryotic-specific, 5 human-specific, and 6 present in both human and prokaryotes) were retained (Figure 1 ). In total, 39 % of the reactions of the network are performed exclusively by bacterial and archaeal species, reflecting the relevance of prokaryotes on the metabolism of indoles. Indole-3-pyruvate is the only indolic compound produced upon human metabolism exclusively, by action of the Lamino-acid oxidase. The production of all remaining indoles requires prokaryotic metabolism, either for all reactions of a given path (indole and indole-3-acetate via indole-3-acetamide) or at least for one of them (indoxyl and indole-3-acetaldehyde). Bacterial metabolism is also required for the synthesis of indole-3-lactate, 3-indoleglycolaldehyde and 3-methylindolepyruvate, although these reactions have not been fully characterised yet (i.e.
the reactions are not linked to a KO ortholog).
BLASTP-based strategy to predict novel key prokaryotic genes and species involved in mammalian-microbial co-metabolism
Next, we used a BLASTP-based strategy to augment the identification of bacterial species involved in indole production reported in KEGG. This approach allowed the identification of 2,626 novel prokaryotic species potentially implicated in indole metabolism (+63.4 % compared to KEGG) (Figure 2a) . For individual reactions, the increases in the number of prokaryotic species ranged from 7 ("K11816") to 1,380 ("K00128") (Figure 2b) .
Similarly, we confirmed that human-specific reactions reported in KEGG were not performed by prokaryotes according to BLASTP searches.
We then applied a filtering strategy to select prokaryotic species present in the human gut (Figure 2c-d) . For this purpose, we constructed a database including gut prokaryote species described in HMP and cultivation studies (Rajilic-Stojanovic and de Vos 2014, Browne, Forster et al. 2016 , Lagier, Khelaifia et al. 2016 , comprising 1,859 organisms from 1,604
species. In the gut-filtered dataset, BLASTP searches predicted a total of 209 novel prokaryotic species (Figure 2c) . While some reactions are performed by a reduced number of species (e.g. "K01593", n = 8 and "K01721", n = 15; corresponding respectively to 0.8 % and 1.7 % of the gut prokaryotic dataset), others (e.g. "K00128") are predicted to be performed by 16.9 % of the gut prokaryotes (n = 254) (Figure 2d and Table 1 ). No gut prokaryotic species were predicted to be able to catalyse the conversion of indolepyruvate into indole-3-acetate.
Prokaryotic communities involved in the production of indole and indole-3-acetate
Having provided an overview of the prokaryotic metabolism of indoles, we then focused on specific indolic compounds reported to be relevant for human health: indole and indole-3-acetate.
Indole is synthesised in the gut upon the action of a prokaryotic lyase, tryptophanase ("K01667"), followed by conversion by hepatic enzymes into indoxyl and 3-indoxylsulphate (Figure 3a) . In total, 93 prokaryotic species are involved in this metabolic conversion, amongst which 30 were newly predicted by BLASTP (Figures 2d and Table 1 ). Data visualization of these species, in the form of a phylum-clustered network, reveals a marked relative contribution of the phyla Proteobacteria and Bacteroidetes (Figure 3a and
Supplementary table 1).
The production of indole-3-acetate exhibits considerable metabolic complexity, occurring through three metabolic paths: via indole-3-acetamide (path-1, exclusively bacterial), via indole-3-pyruvate (path-2) or via tryptamine (both microbial and mammalian co-metabolism)
Microbial reactions, genes and number of species involved in the production involved in the production of indolic compounds from tryptophan, reported in the KEGG orthology database and newly identified by BLASTP searches (+BLASTP). Table 1 . Microbial genes and species involved in indole production from tryptophan.
( Figure 3b ). An overview of the contribution of prokaryotic species to the individual reactions of the three paths is shown in Figure 3c . For each path, the first step is consistently predicted to be the one performed by a lower number of prokaryotic species, suggesting the critical role of a subset of species on the initiation of these metabolic paths.
Prokaryotic species implicated in several steps of the same path, or even in different paths, are likely to be particularly relevant in the synthesis of indole-3-acetate. In order to highlight the most relevant species, we used a scoring system that reflects the overall contribution of each species to these three metabolic paths (Figure 3d) . We then filtered the original heatmap (Figure 3c ) to include species with a SCS > 1.66, which corresponds to the ability to perform at least four of the seven reactions (Figure 3e) . Overall, the species with highest SCS belong to the phylum Proteobacteria. The genus Pseudomonas exhibited particularly high SCSs, with five species (P. putida, P. monteilii, P. mosselii, P. fluorescens, P. libanensis) predicted to be able to perform six out of the seven metabolic reactions involved in the production of indole-3-acetate (Figure 3e) . While most of these species were 
DISCUSSION
Unlike previous studies, we used a systematic computational approach to predict the contribution of the gut microbiota to indole metabolism. The production of most indoles (e.g.
indole and indole-3-acetate) is dependent, at least partially, on microbial metabolism. In contrast, indole-3-pyruvate may be produced by human metabolism only, upon the action of the L-amino-acid oxidase; a secreted enzyme encoded by the gene IL4I1 and expressed in the gastrointestinal tract, particularly in the colon and rectum (Ponten, Jirstrom et al. 2008 ).
The enzyme is released into the intestinal lumen (Ponten, Jirstrom et al. 2008) , where it converts tryptophan into indole-3-pyruvate, which can then be used as a substrate for gut prokaryotic metabolism. Therefore, although indole-3-pyruvate is not a gut microbial metabolite per se, it can be used as a substrate for the production of microbial metabolites, exemplifying an interesting case of mammalian-microbial metabolic cooperation.
Our proposed BLASTP-enhanced strategy, followed by gut microbiota filtering, allowed the prediction of 209 novel species involved in the metabolic conversion of tryptophan into indolic compounds. For the production of indole, we predicted 75 novel species that are not reported in KEGG.
Using phylum-level analysis, we predicted the contribution of individual phyla for the production of different indoles. While mostly Proteobacteria and Bacteroidetes cooperate in the single metabolic step involved in the conversion of tryptophan to indole, for indole-3-acetate, prokaryotic species (belonging to the phyla Proteobacteria, Actinobacteria and
Firmicutes) contribute at a multi-step cooperative level. However, it is important to note that the detection of a protein sequence in a microbe's genome is only an indicator that it may produce a given metabolite from a substrate; it does not guarantee functionality and further in vitro studies are needed to confirm metabolic activity. Validation studies should include qualitative (e.g. Kovac's reagent or Ehrlich's reagent (Lombard and Dowell 1983) 
